Drug companies are pursuing collaborative efforts with other companies to manage in the world of pharmacogenomics and individualized medicine.
Respond to the following in a minimum of 175 words:
- What are some examples of these collaborative efforts by pharmaceutical companies (e.g., Accelerated Medical Partnership (AMP) program)?
- What are some examples of the value in partnerships and collaborations in health care service systems?